GT 2331 selective histamine H3 receptor antagonist:begining a double-blind phase I trail

By WIR Staff | Nov 9, 1998 | 8:00 AM GMT

Gliatech Inc. (GLIA), Cleveland, Ohio
Product:

Read the full 60 word article

How to gain access

Continue reading with a
two-week free trial.